← Back to Search

Sleep Extension for Sleep Disorders

N/A
Waitlist Available
Led By Jennifer Duffecy, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Age 18 to 30
* Have internalizing symptoms (e.g., depression, anxiety, stress)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-treatment and at 6-week post-treatment assessment
Awards & highlights
No Placebo-Only Group

Summary

The goal of this interventional study is to learn if a digital sleep extension intervention can improve sleep and mood in young urban adults with mood symptoms. The main questions it aims to answer are: Will this intervention improve sleep? Will this intervention improve mood? Does the effect of this intervention change based on environmental factors like noise and light pollution? Researchers will compare participants receiving the sleep intervention to participants receiving a "general healthy living" intervention to see if outcome are different across groups. Participants will: * receive 6 weeks of brief once weekly telephone coaching and read once weekly educational content * have their sleep monitored daily with a FitBit and Somnofy sleep device and during the 6-week intervention period * respond to questionnaires at the start of the intervention, halfway through the intervention, at the end of the intervention, and finally 4 weeks after completing the intervention

Eligible Conditions
  • Mental Health Disorders
  • Sleep Disorders

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-treatment and at 6-week post-treatment assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-treatment and at 6-week post-treatment assessment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Feasibility
Internalizing symptoms
+5 more
Secondary study objectives
Bedtime Procrastination
Daytime fatigue
Electronics use before bed

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Sleep ExtensionExperimental Treatment1 Intervention
Sleep-related psychoeducation will be provided in weekly lesson content. Phone coaching will revolve around sleep health and meeting sleep goals.
Group II: Healthy LivingActive Control1 Intervention
Psychoeducation about general health (e.g., hand washing) will be provided in weekly lesson content. Phone coaches will not provide counseling or goal setting but may clarify terms or concepts.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sleep Extension
2017
N/A
~400

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
639 Previous Clinical Trials
1,569,129 Total Patients Enrolled
Jennifer Duffecy, PhDPrincipal InvestigatorUniversity of Illinois Chicago
3 Previous Clinical Trials
382 Total Patients Enrolled
~17 spots leftby Jul 2025